Evogene Ltd.
EVGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $15 | $21 | $29 | $32 |
| Short-Term Investments | $0 | $10 | $6 | $22 |
| Receivables | $1 | $1 | $1 | $1 |
| Inventory | $2 | $0 | $1 | $0 |
| Other Curr. Assets | $3 | $3 | $1 | $2 |
| Total Curr. Assets | $22 | $34 | $38 | $57 |
| Property Plant & Equip (Net) | $4 | $3 | $4 | $4 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $12 | $13 | $14 | $15 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $3 | $0 | $0 | $0 |
| Total NC Assets | $20 | $17 | $18 | $19 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $40 | $51 | $56 | $76 |
| Liabilities | – | – | – | – |
| Payables | $1 | $2 | $1 | $1 |
| Short-Term Debt | $11 | $1 | $1 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $1 | $1 | $0 | $0 |
| Other Curr. Liab. | $6 | $4 | $4 | $4 |
| Total Curr. Liab. | $19 | $7 | $6 | $7 |
| LT Debt | $2 | $11 | $11 | $2 |
| Deferred Rev, NC | $4 | $4 | $5 | $4 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $6 | $15 | $16 | $6 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $3 | $1 | $2 | $3 |
| Total Liabilities | $25 | $22 | $21 | $13 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$274 | -$258 | -$234 | -$207 |
| AOCI | $272 | $269 | $261 | $260 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | -$1 | $12 | $28 | $54 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $16 | $17 | $7 | $10 |
| Total Liab. & Tot. Equity | $40 | $51 | $56 | $76 |
| Net Debt | -$2 | -$9 | -$17 | -$30 |